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Abstract
Obesity is associated with a chronic low-grade inflammation that predisposes to insulin resistance and the development of
type 2 diabetes. In this metabolic context, gastrointestinal (GI) candidiasis is common. We recently demonstrated that the
PPARc ligand rosiglitazone promotes the clearance of Candida albicans through the activation of alternative M2
macrophage polarization. Here, we evaluated the impact of high fat diet (HFD)-induced obesity and the effect of
rosiglitazone (PPARc ligand) or WY14643 (PPARa ligand) both on the phenotypic M1/M2 polarization of peritoneal and cecal
tissue macrophages and on the outcome of GI candidiasis. We demonstrated that the peritoneal macrophages and the cell
types present in the cecal tissue from HF fed mice present a M2b polarization (TNF-ahigh, IL-10high, MR, Dectin-1).
Interestingly, rosiglitazone induces a phenotypic M2b-to-M2a (TNF-alow, IL-10low, MRhigh, Dectin-1high) switch of peritoneal
macrophages and of the cells present in the cecal tissue. The incapacity of WY14643 to switch this polarization toward M2a
state, strongly suggests the specific involvement of PPARc in this mechanism. We showed that in insulin resistant mice, M2b
polarization of macrophages present on the site of infection is associated with an increased susceptibility to GI candidiasis,
whereas M2a polarization after rosiglitazone treatment favours the GI fungal elimination independently of reduced blood
glucose. In conclusion, our data demonstrate a dual benefit of PPARc ligands because they promote mucosal defence
mechanisms against GI candidiasis through M2a macrophage polarization while regulating blood glucose level.
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Introduction
Obesity is associated with a chronic low-grade inflammation that
predisposes to insulin resistance and development of type 2 diabetes.
Increased adiposity promotes macrophage infiltration into adipose
tissue, leading to a local inflammation and insulin resistance.
Adipose tissue macrophages (ATMs) consist of at least two different
phenotypes, i.e, classically activated pro-inflammatory M1 macro-
phages and alternatively activated M2 macrophages. Indeed, a
recent study suggests that diet-induced obesity induces the
recruitment of M1 pro-inflammatory polarized macrophages in
adipose tissue participating in a state of insulin resistance [1]. In
addition, another study also demonstrates that mice deleted for
PPARc, a nuclear receptor involved in adipocyte differentiation and
macrophage M2 alternative polarization [2], displayed insulin
resistance with reduced number and impaired function of M2
macrophages [3]. Conversely, a recent report proposed that the
chronic inflammatory alterations during fat mass development are
associated with increased abundance of macrophages in adipose
tissue which present a particular M2 remodelling phenotype. These
macrophages resembled M2 macrophages phenotypically by
surface expression of Mannose Receptor (MR), CD163 and integrin
avb5, their endocytic activity and production of anti-inflammatory
cytokines (IL-10, IL-1Ra), but represent an unique type of
macrophages that also secrete large amounts of pro-inflammatory
cytokines. Moreover, they showed an endocytic activity similar to
M2 macrophages and accordingly secreted high amounts of IL-10
and IL-1 receptor antagonist. However, basal and induced secretion
of pro-inflammatory mediators TNF-a, IL-6, IL-1b, MCP-1 and
MIP-1a were even higher in ATMs than in proinflammatory M1
macrophages [4]. This macrophage phenotype is similar to theM2b
macrophages established by Mantovani et al, characterized by
abundant levels of non-opsonic receptors (e.g. the MR, CD36) and
high levels of inflammatory cytokine production with concomitant
high IL-10 and low IL-12 [5,6]. These authors have also highlighted
other 2 subtypes of M2 macrophages, M2a and M2c, characterized
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by abundant levels of non-opsonic receptors and by low production
of proinflammatory cytokines (IL-1b, TNF-a and IL-6). Although
several studies have focused on the phenotype of ATM during
metabolic dysregulation, no study has explored the M1/M2
polarization of macrophages in other tissues during metabolic
deregulation.
A causal association between obesity and type II diabetes and an
increased susceptibility to digestive infectious agents is well
recognised [7–10]. Among these infections, Candida species have
been frequently isolated from the oral cavities and GI tract of
patients with diabetes mellitus [11]. A large number of reports
suggest that C. albicans is the most common species identified in the
oral and GI mucosa of these sensitive patients. The predisposition
of the diabetics to infections by pathogenic fungal species has been
explained in terms of enhancement of yeast growth by elevated
tissue fluid glucose levels. Moreover, the presence of a high
concentration of salivary glucose combined with low salivary
secretion may enhance growth of yeasts and their adherence in
epithelial oral cells [12]. Thus, as the macrophages are key cells in
fungal elimination, it is important to determinate their phenotype
in digestive mucosal tissues.
We previously reported that IL-13, a Th2 cytokine, promotes in
vitro and in vivo the elimination of C. albicans by increasing the
expression at the surface of macrophages of MR and Dectin-1, C-
type lectin receptors involved in non-opsonized C.albicans recog-
nition and phagocytosis and also in the production of reactive
oxygen species [13–15]. In addition, we demonstrated that this
increase of MR and Dectin-1 expression by IL-13, characteristic of
M2 polarization, involved the activation of the nuclear receptor
PPARc. We also showed that this macrophage M2 activation by
IL-13 can also be reproduced by rosiglitazone, a synthetic PPARc
ligand used as an antidiabetic drug. Conversely, we determined
that IFNc, a Th1 cytokine, inhibits the non-opsonized C.albicans
phagocytosis by decreasing C-type lectin receptor expression on
macrophage surface, but eliminates yeast by increasing the
expression of opsonized receptors at the surface of macrophages
and the macrophage inflammatory properties [16]. All these data
clearly demonstrate the complementarities of these 2 types of
macrophage polarization in the elimination of fungal infection.
In the present study, we evaluated the impact of insulin
resistance induced by high fat diet (HFD) and the effect of
rosiglitazone (PPARc ligand) or WY14643 (PPARa ligand) on the
phenotypic differentiation of peritoneal macrophages and of the
cell types present in the cecal tissue. We then determined whether
their polarization could modify their anti-fungal functions. We
demonstrated for the first time that the peritoneal macrophages
and the cell types present in the cecal tissue from HF fed mice
present a M2b polarization. Interestingly, only rosiglitazone
treatment induces a phenotypic switch of macrophages into M2a
state. In addition, we show that the M2b macrophage polarization
in insulin resistant mice is associated with an increased
susceptibility to GI fungal infections, whereas M2a polarization
after rosiglitazone treatment favours the GI candidiasis elimination
independently of reduced blood glucose. These findings demon-
strate in a hyperglycaemic metabolic context a dual benefit of
PPARc ligands, which are able to regulate blood glucose level and
strengthen M2a defence of macrophages during fungal infections.
Results
Validation of diet-induced diabesity mice model
We compared weight evolution of mice fed either chow or HFD
for three months (Figure 1A). When fed a HFD, mice gained
significantly more weight than mice fed standard chow. The
differences in body weight were accounted for by an increased fat
mass, as mirrored by the weight of the epididymal white adipose
tissue (Figure 1B). In addition, WY 14643 treatment do not change
the weight of white adipose tissue of mice both under chow and
HF fed conditions. Rosiglitazone increases the weight of white
adipose tissue of mice under HF diet, confirming the role of this
drug in adipocyte differentiation.
The increase in body weight in mice under HFD is
accompanied by a reduced metabolic control as evidenced by
the higher fasting plasma glucose. Furthermore, mice in HF fed
condition cleared glucose less effectively after i.p. glucose injection
than animals fed chow diet (Figure 1C). The rate of glucose
clearance upon i.p. insulin injection was also lower in mice fed
HFD, further suggesting insulin resistance (Figure 1D). Altogether
these data demonstrate that after three months of HFD mice
developed all the characteristics of type 2 diabetes.
Macrophage M2 polarization induced by HFD is
potentiated by rosiglitazone
To define the polarization of peritoneal macrophages from
untreated or treated mice in chow and HF fed conditions, the
expression of M1 and M2 macrophage activation state markers was
assessed by flow cytometry and RT-PCR (Figure 2). We observed
that the peritoneal macrophages from mice in HF fed condition
express more strongly the proteins encoding for the MR, Dectin-1
and CD36, established markers of alternative M2 macrophage
activation (Figure 2A). In addition, YM-1, YM-2 and Arginase 1
mRNA levels, other M2 markers, are also increased by HFD
(Figure 2B). In contrast, HFD decreases CD11b expression, a M1
polarization marker, at the surface of macrophages. Interestingly,
following rosiglitazone treatment, the expression of theMR, Dectin-
1, CD36 and TLR-2, receptors known to be involved in pathogen
elimination, at the surface of macrophages from mice both in chow
and HF fed conditions were significantly higher (Figure 2A). In
contrast, the rosiglitazone treatment decreased CD11b expression.
Moreover, the treatment with WY14643 increases slightly Dectin-1
expression at the macrophage surface and does not alter the
expression of other receptors involved in innate immune defence. As
rosiglitazone, WY14643 treatment decreased CD11b expression.
These data demonstrate that HFD favours the polarization of
peritoneal macrophages towards a M2 profile and that this
differentiation is strongly potentiated by rosiglitazone, whereas
WY14643 has a weaker effect.
Macrophage M2b polarization induced by HFD is
switched by rosiglitazone in an M2a state
To establish the precise phenotype of peritoneal macrophages
from untreated or treated mice in chow and HF fed conditions, we
evaluated the transcripts for some inflammatory cytokines
(Figure 3A). In parallel, the capacity of these macrophages to
produce TNF-a and IL-10 cytokines in response to C. albicans was
also tested (Figure 3B). TNF-a mRNA levels increased significantly
in macrophages from mice under HFD. This finding was further
reflected by the increase of TNF-a production by these macro-
phages in response to Candida challenge (Figure 3B). The expression
of IL-6, IL-1b and IL-10 mRNA is not affected by HFD.
Furthermore, rosiglitazone and WY14643 treatments of mice
under HFD conditions induced a decrease in the expression of
TNF-a, as well as in that of two other pro-inflammatory cytokines
(IL-6 and IL-1b). The anti-inflammatory cytokine IL-10 mRNA
level in macrophages from mice under HFD is also reduced by the
treatments with rosiglitazone and WY14643 (Figure 3A). In line,
the same profile of IL-10 production by macrophages in response
M2 Macrophage, Candida Diabetes
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to fungal challenge was obtained (Figure 3B). Overall, these results
demonstrate that HFD induced a M2b (TNFahigh, IL-10high, MR,
Dectin-1) polarization and rosiglitazone switches the polarization
from an M2b to an M2a (TNFalow, IL-10low, MRhigh, Dectin-
1high) phenotype.
HFD-induced M2b polarization and rosiglitazone-
induced M2a polarization are associated with an
up-regulation of PPARc expression
Because PPARc regulates the MR, Dectin-1 and CD36
[13,15,17], characteristic markers of M2 macrophage, we
evaluated PPARc mRNA and protein levels in macrophages
(Figure 3C and D). PPARc mRNA and protein levels are
significantly increased in macrophages from mice under HFD
(Figure 3C and D). The expression of PPARa mRNA is not
modified by the HFD and by rosiglitazone (Figure 3C). Under
HFD conditions PPARd/b is increased by rosiglitazone treatment,
confirming that PPARd/b is induced by rosiglitazone via a PPARc
dependent mechanism [18] (Figure 3C). These data demonstrate
that the specific increase of PPARc mRNA and protein levels by
HFD is correlated with the orientation towards M2 macrophage
phenotype. In this state, the macrophages are specifically sensitive
to rosiglitazone PPARc ligand treatment.
HFD and rosiglitazone trigger the recruitment to the
cecal tissue of M2 macrophages
As diabetes mellitus is associated with infectious and inflam-
matory disorders of GI tract, we determine the recruitment and
the M1/M2 phenotype of macrophages present in the cecal tissue
by confocal microscopy. As expected, an increase in the
recruitment of macrophages in the cecal tissue was observed
upon feeding a HFD (HF C) (Figure 4). Some macrophages are
positive for both the MR and Dectin-1, strongly suggesting a M2
polarization. Interestingly, following rosiglitazone treatment a
significantly larger number of macrophages are both MR and
Dectin-1 positive, demonstrating that the cecal macrophages are
mainly polarized M2 (NC R and HF R). These results
demonstrate that the HFD promotes the recruitment of M2
macrophages to the cecal tissue and that rosiglitazone amplifies
this infiltration.
In the digestive cecal tissue, we have evaluated the mRNA
levels of macrophage specific markers and the inflammatory
profile of this tissue by RT-PCR. We showed that Dectin-1, MR,
CD36, YM-1 and Arginase 1 mRNA levels, established M2 markers,
are increased in cecal tissue from mice in HF fed conditions
(Figure 5). However, HFD decreases CD11b expression, a M1
polarization marker. The expressions of the Dectin-1, MR, CD36,
YM-1 and Arginase 1 in cecal tissue from mice under chow diet
were significantly higher after rosiglitazone treatment. These
increased expressions were potentiated in cecal tissue from mice
under HFD. Moreover, the treatment with WY14643 did not
change the mRNA profile of cecal tissue from mice under HFD.
In addition, the cytokine profile showed an increase of
proinflammatory cytokines (TNF-a, IL-1b) and also of IL-10
anti-inflammatory cytokine in cecal tissue from mice under HF
diet. In addition, rosiglitazone and WY14643 treatments of mice
under HFD conditions induced a decrease in the expression of
Figure 1. Validation of diet-induced diabesity mice model. (A) Weight gain of C57BL/6 mice (n = 18) after three months of chow (NC) or high
fat (HF) diet. (B) Weight of the epididymal white adipose tissue measured after euthanasia of chow or HF fed mice treated or not with rosiglitazone (R)
or WY 14643 (WY) (28 mg/10 g of mouse) (n = 6). (C) Serum glucose levels evolution during an i.p. glucose tolerance test performed after a glucose
load (1 g/kg) in chow or HF fed, 6 hrs-fasted mice. The asterisks refer to all time points. (D) Serum glucose levels evolution during an i.p. insulin
sensitivity test performed after an insulin load (0.5 U/kg) in chow or HF fed, 6 hrs-fasted mice. The asterisks refer to all time points. Data are
represented as mean6 SEM **p,0.01 compared to NC control (NC C).#p,0.05 compared to HF control (HF C). The data are representative of three
independent experiments.
doi:10.1371/journal.pone.0012828.g001
M2 Macrophage, Candida Diabetes
PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e12828
TNF-a and IL-10. The similarity between the mRNA profiles
obtained in peritoneal macrophages and in the cecal tissue
suggests that mucosal macrophages from HFD mice exhibit a
M2b phenotype and that rosiglitazone shifts this M2b polariza-
tion towards a M2a phenotype. As in peritoneal macrophages,
PPARc mRNA level is increased in digestive cecal tissue from
mice under HFD and rosiglitazone treatment potentiates this
increase, confirming the involvement of PPARc in the orientation
towards M2 phenotype.
Rosiglitazone, but not WY 14643, decreases Candida GI
colonization in insulin resistant mice
To evaluate the impact of digestive mucosal macrophages
polarization induced by HFD and rosiglitazone or WY14643
Figure 2. HFD-induced peritoneal macrophage M2 polarization and rosiglitazone treatment potentiated this phenotype. (A) Dectin-
1, MR, CD36, CD11b and TLR2 protein expressions on peritoneal macrophages from mice fed a chow (NC) or a HFD (HF) and treated or not (C) with
rosiglitazone (R) or WY14643 (WY) evaluated by flow cytometry (n = 6). (B) Arginase 1, YM-1 and YM-2 mRNA expressions on peritoneal macrophages
from mice fed a chow (NC) or a HFD (HF) and treated or not (C) with rosiglitazone (R) or WY14643 (WY) by RT-PCR (n = 6). Data are represented as
mean 6 SEM *p,0.05 and **p,0.01 compared to NC control (NC C); #p,0.05 and ##p,0.01 compared to HF control (HF C). The data are
representative of three independent experiments.
doi:10.1371/journal.pone.0012828.g002
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treatments on the outcome of gastrointestinal candidiasis, common
infection during metabolic disorders, we subjected diet-induced
diabesity mice to oral inoculation with C. albicans. After infection,
the mice under HFD have a high fasting blood glucose level and
short term rosiglitazone or WY14643 treatments did not affect
blood glucose level (Figure 6A).
After one week of infection with C.albicans, the body weight of
mice, which reflects their general health condition, was followed
(Figure 6B). The mice under HFD loose more weight than mice
under chow diet. When fed a chow diet, the mice have a slight
loss of weight due to the gavage. Moreover, only rosiglitazone
treatment of mice under HFD reverses significantly this weight
loss. These data are in line with the evaluation of C.albicans GI
colonization (Figure 6C). Indeed, in this model of candidiasis, the
yeast only extensively colonized the oesophagus and the GI tract
of mice under HF diet. No yeast was detectable in GI tract of
mice fed chow diet (,104), demonstrating that these lean mice
are able to resolve the infection and that this metabolic
dysregulation favors Candida infection. Interestingly, after treat-
ment with rosiglitazone the number of yeast in oesophagus,
stomach, and cecum was significantly decreased, whereas
WY14643 treatment has no effect. This clearly demonstrates
the protective effect of rosiglitazone against C.albicans mucosal
colonization during type 2 diabetes.
Rosiglitazone induced-M2a polarization is associated
with the increase of anti-infectious properties
As the HFD and rosiglitazone differentially polarize the
macrophage and that the responses against Candida albicans are
different, we wondered whether the macrophage mechanisms of
pathogen elimination (phagocytosis and reactive oxygen species
production) were also modified.
When macrophages were harvested on mice under HF diet, the
number of C. albicans ingested increased significantly compared to
macrophages from mice under chow diet (Figure 7A). Moreover,
the phagocytosis is strongly increased by rosiglitazone treatment
whatever the diet of the mice. Following the treatment with WY
14643, the capacity of macrophages from mice under HFD to
uptake C. albicans is not modified.
Using chemoluminescence, we next investigated the effect of
rosiglitazone or WY14643 treatments on the production of
oxidizing agent by macrophage in response to Candida challenge
(Figure 7B) or to TPA (Figure 7C). In response to a C. albicans
Figure 3. Rosiglitazone switches HFD-induced M2b polarization towards M2a. (A) TNF-a, IL-1b, IL-6 and IL-10 mRNA expressions in
peritoneal macrophages from mice fed a chow (NC) or a HFD (HF) and treated or not (C) with rosiglitazone (R) or WY14643 (WY) by RT-PCR (n = 6). (B)
TNF-a and IL-10 release by peritoneal macrophages from mice fed a chow (NC) or a HFD (HF) and treated or not (C) with rosiglitazone (R) or WY14643
(WY) by ELISA (n = 6). (C) PPARc, PPARa and PPARb/d mRNA expressions in peritoneal macrophages from mice fed a chow (NC) or a HFD (HF) and
treated or not (C) with rosiglitazone (R) or WY14643 (WY) by RT-PCR (n = 6). (D) PPARc protein level in peritoneal macrophages from mice fed a chow
(NC) or a HFD (HF) and treated or not (C) with rosiglitazone (R) or WY14643 (WY) by western blot. Data are represented as mean 6 SEM *p,0.05
and** p,0.01 compared to NC control (NC C); #p,0.05 compared to HF control (HF C). The data are representative of three independent
experiments.
doi:10.1371/journal.pone.0012828.g003
M2 Macrophage, Candida Diabetes
PLoS ONE | www.plosone.org 5 September 2010 | Volume 5 | Issue 9 | e12828
challenge, the HFD induced a significant increase of ROS
production. In addition, in particular rosiglitazone and to a lesser
extent WY14643 amplified this production whatever the diet
(Figure 7B). The TPA stimulation shows that there is no increased
production of reactive oxygen species (ROS) by macrophages from
mice treated with rosiglitazone under HFD (Figure 7C). However,
macrophages from mice both in chow and HF fed conditions and
treated with WY 14643 produce more ROS in response to TPA.
The increased ROS production in macrophages from mice treated
with WY14643 comes from a direct activation of NADPH oxidase.
Altogether these data show that the macrophage M2a
phenotype induced by rosiglitazone is coupled with the increase
of their capacity to internalize Candida and to produce ROS in
response to Candida challenge.
Figure 4. HFD and rosiglitazone treatment trigger recruitment to the cecal tissue of M2 macrophages that over express the MR and
Dectin-1. Confocal laser microscopy of cecum tissues from untreated (C), rosiglitazone (R) or WY14643 treated chow (NC) or HF fed mice. The blue
color represents the macrophages; red represents Dectin-1 positive cells; green represents MR positive cells. Merged picture of green, red and blue
colors represents triple positive cells. Staining is representative of at least three different cecal tissue samples of three animals by group.
doi:10.1371/journal.pone.0012828.g004
M2 Macrophage, Candida Diabetes
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Discussion
Many previous studies have established the relationship between
dyslipidemia, type 2 diabetes, and immune dysfunction [19].
Indeed, inflammation and inflammatory cells have been described
to be key regulators in obesity and insulin resistance. Several
recent studies have focused on the role of adipose tissue
macrophages (ATMs) in obesity-associated inflammation and
insulin resistance. In HFD-induced obesity murine model it has
been demonstrated that the ATMs recruited in response to HFD
express mixed M1/M2 and remodelling transcriptional profiles
and that these profiles become more M2-like with extended HFD
feeding [20]. In line, the human ATMs have recently been shown
to express mixed M1/M2 remodelling phenotypes [4,20,21]. In
contrast, other studies reported the recruitment of M1 pro-
inflammatory polarized macrophages in adipose tissue of obese
mice [1,22]. Here, we have explored for the first time the M1/M2
polarization of macrophages of peritoneal and digestive mucosal
macrophages during HFD-induced obesity. Indeed, the peritoneal
macrophages, which are an abundant source of macrophages, are
Figure 5. The cell types present in the cecal tissue from HFD mice exhibit a M2b phenotype which is shifted by rosiglitazone
towards M2a. Dectin-1, MR, CD36, CD11b, YM-1, Arginase 1, TNF-a, IL-1b, IL-10 and PPARc mRNA expressions on cecal tissue from mice fed a chow
(NC) or a HFD (HF) and treated or not (C) with rosiglitazone (R) or WY14643 (WY) evaluated by RT-PCR (n = 6). Data are represented as mean 6 SEM
*p,0.05 and **p,0.01 compared to NC control (NC C); #p,0.05 compared to HF control (HF C). The data are representative of three independent
experiments.
doi:10.1371/journal.pone.0012828.g005
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close to the visceral adipose tissue and hence their polarization
could be influenced by the fat mass. In addition, as diabetic
patients are at risk of acquiring digestive infections and as the
macrophages are key cells in pathogen elimination, it is important
to determinate their phenotype in intestinal tissue. In this context,
we determined characteristic markers of M1 and M2 macrophage
polarization and demonstrate that the peritoneal and cecal
macrophages from mice under HFD exhibit an alternative M2
polarization. Indeed, the MR, Dectin-1, CD36, YM-1, YM-2 and
Arginase 1 expressions are greatly enhanced by the HFD, this
induction being characteristic of the M2 macrophage polarization
[23]. Cytokine profiling is also an important determinant of the
precise phenotype of macrophages. Peritoneal macrophages and
cecal tissue from mice on HFD have a particular phenotype as
they express both IL-10, characteristic of M2 phenotype, and also
TNF-a, IL-6 and IL-1b proinflammatory cytokines, typical of M1
macrophages. These results are fully in line with a report of
Mantovani et al. indicating that M2 macrophages are divided into 3
subtypes (M2a, M2b, M2c) characterized by a different cytokine
profile [5]. It is clear that the peritoneal macrophages and the cell
types present in the cecal tissue of insulin resistant mice correspond
to M2b macrophage subtype. Our results hence confirm those of
Bourlier et al, which demonstrated this particular M1/M2
phenotype in macrophages from adipose tissue of obese patients
[4,21] and thus reinforce the concept that metabolic abnormalities
polarize macrophages, whatever their tissular origin, towards M2
macrophages.
PPARc nuclear receptor is essential both during adipogenesis
and maturation of alternatively activated M2 macrophages [2].
We demonstrate here that HFD conditions increase specifically
PPARc mRNA and protein levels. This induction of PPARc
expression by HFD is consistent with other studies, which showed
the increase of PPARc in white adipose tissue of obese mice [24]
and in macrophages of monkeys under HFD conditions [25]. The
induction of PPARc is conflicting with the literature, which
generally shows a decrease of PPARc expression during
inflammatory context [26,27]. However, a pathway involved in
PPARc expression in hyperglycaemia was described. It depends
on the activation of Nrf2 pathway through the generation of ROS
occurring during the low grade inflammation [28,29]. Concom-
itantly with this PPARc induction, we observed an increase of MR
and Dectin-1, in line with our previous results which showed that
PPARc was involved in the signalling pathway that regulates MR
and Dectin-1 expression in macrophages [12,14]. Surprisingly, in
contradiction with the anti-inflammatory properties of PPARc
[30], there is also an increase of the expression of pro-
inflammatory cytokines. All these data suggest that there is a lack
of activation of PPARc, caused either by a lack of endogenous
ligands or by a loss of its functionality. The defect can be reversed
by the addition of exogenous ligands, demonstrating that PPARc
activity is not affected by the diet. Indeed, the treatment of insulin
resistant mice with rosiglitazone potentiates the induction of MR
and Dectin-1 and restores the anti-inflammatory activity of
PPARc. We established that the treatment of insulin resistant
mice with rosiglitazone induced a M2b to M2a switch of their
peritoneal macrophages and of the cell types present in the cecal
tissue, characterized by a weak production of proinflammatory
cytokines (TNF-a, IL-6 and IL-1b) and IL-10 and a strong
expression of the MR, Dectin-1, CD36 and TLR2. Moreover, the
WY14643 treatment orientates the polarization of macrophages
toward a particular phenotype, near of M2a by their cytokine
profile (low production of IL-10 and TNF-a). These macrophages,
however, do not represent true M2a macrophages, because they
express low levels of MR and Dectin-1. The lack of induction of
Figure 6. Rosiglitazone attenuates GI candidiasis during type II diabetes. (A) Blood glucose levels of mice fed a chow (NC) or a HFD after
infection with C. albicans (50.106 yeasts/mouse) and treatments with rosiglitazone (R) and WY14643 (WY) (n = 6). (B) Weight gain of these mice after
infection with C. albicans. (C) C. albicans GI colonization of esophagus, stomach and cecum of mice fed a HFD and treated or not (HF C) with
rosiglitazone (HF R) and WY14643 (HF WY) evaluated by RT-PCR. Data are represented as mean 6 SEM *p,0.05 and **p,0.01 compared to NC
control (NC C); #p,0.05 compared to HF control (HF C). The data are representative of three independent experiments.
doi:10.1371/journal.pone.0012828.g006
M2 Macrophage, Candida Diabetes
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MR and Dectin-1 by WY14643 shows the specificity of PPARc in
the signalling pathway that regulates these two receptors. In
addition, this study reinforces that PPARa may be involved with
PPARc in the suppression of pro-inflammatory cytokines. Indeed,
several studies imply also an anti-inflammatory role for PPARa
which interferes with the NF-kB and AP-1 inflammatory pathways
[31].
The macrophage M2b phenotype induced by HFD is
characterized by the increase of MR and Dectin-1-dependent
microbicidal ex vivo functions against C. albicans, most common
specie identified in the oral and GI mucosa of diabetic patients.
However, our data underscore that insulin resistant mice are more
susceptible to sustained GI Candida colonization than lean mice.
These findings are in line with increased susceptibility to
candidiasis in patients with metabolic dysregulation [9]. This
discrepancy between the ex vivo and in vivo data is attributed to the
fact that the in vivo Candida elimination involves both opsonin-
dependent and independent host defence mechanisms, while in
our ex vivo experimental conditions, only the elimination of non-
opsonized C. albicans is implicated. Altogether, these results
strongly suggest that the HFD may affect other immune functions
involved in the opsonized C. albicans elimination through M1
activation. Consistent with this hypothesis, we demonstrated that
the CD11b complement receptor type 3, the principal adhesion
receptor on leukocytes for Candida albicans [32] is strongly
decreased in macrophages from mice under HF diet, suggesting
a default of pathogen-opsonised recognition in this dyslipidemic
context. In line, different disturbances in innate humoral immunity
were previously described in diabetic patients. Indeed, the
expression of complement receptor 3 on monocytes from non-
insulin-dependent diabetes patients was strongly decreased and the
CD55 and CD59 complement regulatory protein-positive mono-
cytes were lower in type 2 diabetic patients [33–36].
Interestingly, the rosiglitazone-induced M2a polarization com-
pensates the defect of the humoral innate immune response.
Indeed, this M2a macrophage polarization is correlated with
improved elimination of GI C. albicans. In this state the peritoneal
macrophages strongly express the MR and Dectin-1 on their
surface and thus the antifungal functions associated with these
receptors (phagocytosis and ROS production) are robustly
increased. Moreover, the mucosal macrophages present on the
infection site share the same M2a phenotype and hence could
participate actively to Candida elimination in digestive tract. These
data are consistent with previous results showing that PPARc
specific ligands enhance fungal clearance in immunodeficient Rag-
2-/- mice, reinforcing the concept that the M2a polarization
induced by PPARc ligands is able to thwart the lack of humoral
immune response [14]. Moreover, our data indicate that short-
term rosiglitazone treatment was ineffective to decrease blood
glucose levels. These observations are consistent with previous
studies showing that 3 weeks of rosiglitazone treatment are not
sufficient to reduce hyperglycemia in a transgenic mouse model of
type 2 diabetes and that in general 4–5 weeks of treatment are
necessary to reduce blood glucose level in mice on HFD [37,38].
Likewise, in humans, at least 2 weeks of therapy are necessary to
see an effect on blood glucose level. Altogether these data reveal
that the anti-fungal effect of rosiglitazone is independent of
changes in blood glucose level and is strictly correlated to the M2a
macrophage polarization.
On the other hand, the decrease in Candida GI colonization is
not observed in mice treated with the WY14643 (PPARa ligand),
demonstrating the specific effect of PPARc. Unlike rosiglitazone,
WY14643 increase slightly MR and Dectin-1 and thus the
antifungal functions of macrophages are not induced. In addition,
the absence of a WY14643-mediated induction of the expression
of TLR2, receptor known to collaborate with Dectin-1 to promote
macrophage antifungal functions [39], contributes to the lack of
Figure 7. Rosiglitazone treatment promotes the candidacidal
activity of macrophages from insulin resistant mice. (A) Index of
phagocytosis of non-opsonised C.albicans by peritoneal macrophages
collected from mice fed a chow (NC) or a HFD (HF) and treated or not
(C) with rosiglitazone (R) or WY14643 (WY) (n = 6). The phagocytosis of
non-opsonised C.albicans by macrophages was measured at 37uC after
challenge with FITC-labeled C.albicans for 60 min by flow cytometry.
(B–C) ROS production of peritoneal macrophages from mice fed a chow
(NC) or a HFD (HF), untreated (C) or treated with rosiglitazone (R) and
WY14643 (WY) (n = 6). Non-opsonised C.albicans (B) or TPA (C)-induced
respiratory burst of macrophages was measured by chimiluminescence.
Total chimioluminescence emission (area under the curve expressed in
counts x seconds) was observed continuously for 60 min in the
presence or absence of C. albicans or TPA. Data are represented as
mean 6 SEM ** p,0.01 compared to NC control (NC C); #p,0.05
compared to HF control (HF C). The data are representative of three
independent experiments.
doi:10.1371/journal.pone.0012828.g007
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induction of anti-infectious functions of macrophages and hence
explains the ineffectiveness of PPARa ligands in Candida
elimination.
In conclusion, we established that the peritoneal macrophages
and the cell types present in the cecal tissue during metabolic
disorders present a M2b phenotype. This polarization under
insulin resistance is associated with an increased susceptibility to
GI fungal infections. Rosiglitazone treatment induces a phenotypic
M2b-to-M2a switch of macrophages, which promote mucosal
defence mechanisms against GI candidiasis. Our findings hence
demonstrate a dual benefit of PPARc ligands, which are able to
promote mucosal defence mechanisms against GI candidiasis on
the one hand through M2a polarization and on the other hand by
lowering blood glucose levels.
Materials and Methods
Mice and experiments
All animal experimentation was conducted in accordance with
accepted standards of humane animal care. Mouse experiments
were approved and performed according to the guidelines of the
Toulouse University Animal Safety Committee and of the
Regional Safety Committee (Procedure 1992). This study was
carried out in accordance with Approval No. A3155503 and all
procedures for animal care and maintenance conformed with the
French and European Regulations (Law 87-848 dated 19/10/
1987 modified by Decree 2001-464 and Decree 2001-131 relative
to European Convention, EEC Directive 86/609 dated 24/11/
1986).
The model of type 2 diabetes was induced on 6-wk-old male
wild-type C57BL/6 mice (Janvier, France) by a high fat diet (Safe,
49.5% of calories from lipids) for 12 weeks. The mice’s weight was
monitored once a week. All cages were changed twice weekly, and
all manipulations of the animals were done in a laminal blow hood
under aseptic conditions. The photoperiod was adjusted to 12 h
light and 12 h dark. After 12 weeks of the high fat diet, we
established esophageal and GI candidiasis on half of the mice by
performing intraesophageal infection with 56107 viable cells of
Candida albicans in sterile saline solution (500 ml/mouse). At this
level of infection, the fungal colonization in mice under chow diet
was undetectable after one week, as described previously [15]. On
day 8 after infection, all mice were euthanized using CO2
asphyxia.
Treatment groups
Therapeutic studies were performed on separate groups of six
mice, infected or not by C. albicans. Mice were treated with
rosiglitazone (Cayman Chemical) or WY 14643 (Calbiochem) 1
day before, the day of the infection with C. albicans and then every
2 days (28 mg/10 g of mouse) (five injections). Control groups
received saline solution only with DMSO. The body weight of
each mouse was recorded daily.
IntraPeritoneal Glucose Tolerance Test (IPGTT)
After 12 weeks of the HF diet, 3 animals per group were fasted
for approximately 6 hours and a solution of 20% of glucose was
then administered by intra-peritoneal (IP) injection (1 g of
glucose/kg mouse) and blood glucose was measured at different
time points (0, 15, 30, 45, 120 min).
IntraPeritoneal Insulin Sensitivity Test (IPIST)
After 12 weeks of the HF diet, 3 animals per group were fasted
for approximately 6 hours and insulin was then administered by
intra-peritoneal injection (0.5 U/kg of mouse) and blood glucose
was measured at different time points (0, 15, 30, 45, 60 min).
Candida albicans strain
The strain of Candida albicans used throughout these experiments
was isolated from a blood culture of a Toulouse-Rangueil Hospital
patient. The isolate was identified as C. albicans based on common
laboratory criteria (BichroLatex C.albicansH (Fumouze), Mini APIH
test (Bio Merieux)) and cultured on Sabouraud dextrose agar
(SDA) plates containing gentamicin and chloramphenicol. C.
albicans was maintained by transfers on SDA plates. Growth from
an 18 to 24 h SDA culture of C. albicans was suspended in sterile
saline.
Fluorescent C.albicans was prepared by adding C.albicans to
fluoroscein isothiocyanate (FITC, Sigma) dissolved in sodium
carbonate buffer (pH 9.5) at room temperature for 3 h and
washed by centrifugation three times in sodium carbonate buffer
before storage in aliquots of water at 4uC.
Quantification of C. albicans in the esophagus and GI
tract
Cell lysis and DNA extraction. After mouse euthanasia, esophagus,
stomach and cecum were aseptically removed to evaluate C.
albicans colonization. These organs were then crushed using lysing
matrix tubes (MP Biomedicals). A total of 250 ml of each tissue
sample homogenate was resuspended in 200 ml of lysis buffer for
2 h at 65uC (High Pure PCR Template preparation kit, Roche
diagnostics). Another lysis step was then performed with binding
buffer for 10 minutes at 72uC. DNA was then extracted with
isopropanol. The lysis reaction was stopped with inhibitor buffer
and a serie of 2 washes were then performed. DNA was eluted
with an elution buffer.
Light Cycler-based PCR assay. The Light Cycler PCR and
detection system (Roche Diagnostics) was used for amplification
and online quantification. PCR analysis was performed as
described [14]. Serially diluted samples of genomic fungal DNA
obtained from C. albicans cultures (40.106 cells) were used as
external standards in each run. Cycle numbers of the logarithmic
linear phase were plotted against the logarithm of the concentra-
tion of template DNA to evaluate the number of yeast cells present
in each tissue sample homogenate.
Preparation of mouse resident peritoneal macrophages
After euthanasia, resident peritoneal cells were harvested by
washing the peritoneal cavity with 5 ml of sterile PBS medium.
Collected cells were centrifuged at 400 g for 10 min and the cell
pellet was suspended in Dulbecco’s modified Eagle’s medium
(DMEM, Gibco Invitrogen Corporation) supplemented with
glutamine (Gibco Invitrogen Corporation), penicillin, streptomy-
cin (Gibco Invitrogen Corporation) and 5% heat-inactivated fetal
calf serum. Cells were allowed to adhere for 2 h at 37uC and 5%
CO2. Non adherent cells were then removed by washing with
PBS.
Flow cytometry
The analysis was performed on non adherent macrophages
[15]. Surface expressed Dectin-1 or CD36 was detected
respectively using FITC-Dectin-1 mAb (Serotec) or PE-
CD36 mAb (Santa Cruz) and was compared with an irrelevant
appropriate isotype control. The labeled mAbs anti-CD11b-Alexa
647, and anti-TLR2-Alexa 488 were obtained from Serotec. To
evaluate the Mannose Receptor (MR) surface expression, we have
used MR-specific ligand conjugated with FITC (Sigma). A
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population of 10 000 cells was analyzed for each data point. All
analyses were done in a Becton Dickinson FACScan using
CellQuestPro software.
Reverse transcription and real-time PCR
Total RNA obtained from peritoneal macrophages or cecum
tissue was prepared with RNeasyH Mini Kit columns (Qiagen)
using the manufacturer’s protocols. Synthesis of cDNA was
performed from 1 mg of total RNA with QuantiTectH Reverse
Transcription (Qiagen) according to the manufacturer’s recom-
mendations and primed with hexamers. Quantitative real-time
PCR was performed on a LightCycler system (Roche Diagnostics)
using QuantiFastTM SYBRH Green PCR (Qiagen). Ten micro-
liters of reaction mixture was incubated; the amplifications were
performed for 50 cycles (10 s at 95uC and 60 s at 60uC). The
primers (at a final concentration of 10 mM) were designed with
the software Primer 3 and listed in Table 1. b-actin mRNA was
used as the invariant control.
ELISA Cytokine titration
Peritoneal macrophages were added to 96 well plates
(2.105macrophages/well) then stimulated with non-opsonised
C.albicans at a yeast-to-macrophage ratio of 3:1 for 1 h.
Supernatants were recovered and frozen at270uC before analysis.
The production of TNF-a and IL-10 in the cell supernatants was
determined with a commercially available OptiEIA kit (BD
Biosciences) according to the manufacturer’s instructions.
Western Blot Analysis
Total protein lysates were extracted with 25 mM Tris pH 8,
200 mM glycine, 0.25% SDS and anti-protease cocktail (Roche).
After protein transfer,membranes were incubated overnight
at 4uC with a rabbit polyclonal anti-PPARc (Santa Cruz) and
then for 1 h at 21uC with a peroxidase conjugate secondary
antibody. Membranes were washed, and proteins were visualized
with the SuperSignal West Pico Chemiluminescent Substrate
(ThermoScientific).
Phagocytosis assay
For analysis of phagocytosis of C.albicans, cultured macrophages
were challenged with six FITC labeled yeasts per macrophage and
phagocytosis was initiated at 37uC in an atmosphere of 5% CO2
in 48 well Falcon plates (5.105 macrophages/well). Phagocytosis
was stopped after 60 min by washing the macrophages with ice-
cold PBS. Macrophage monolayers were incubed with ice-cold
PBS-EDTA (5 mM) and gently scarped. The number of C.albicans
engulfed by macrophages was determined using FACS based
approach. The distinction between internalised yeast cells and
yeasts attached to macrophages surface was done via quenching of
FITC fluorescence by trypan blue. The remaining fluorescence
was quantified on a Becton Dickinson FACScan using CellQuest-
Pro software and used as indicator of the phagocytosis efficiency.
Assay for oxidizing agent production
The macrophages were plated in 96 well Falcon plates (3.105
macrophages/well). The oxygen dependent respiratory burst of
macrophages was measured by chemiluminescence in the presence
of 5-amino-2,3-dihydro-1,4-phthalazinedione (luminol) using a
thermostatically (37uC) controlled luminometer (Wallac 1420
Victor2). The luminol detects both reactive oxygen and nitrogen
intermediates (O2.-, ONOO-, OH.). The generation of chemo-
luminescence was monitored continuously for 1 h after incubation
of the cells with luminol (66 mM) and after 12-O-tetradecanoyl-
phorbol-13-acetate (TPA, 100 mM) or after C. albicans challenge at
a yeast-to-macrophage ratio of 3:1. Statistical analysis was
performed using the area under the curve expressed in counts x
seconds.
Immunohistochemical analysis of cecum macrophages
Cecum tissues of wild-type mice treated or not with rosiglita-
zone or WY 14643 were removed, and carefully opened
longitudinally [14].After washing in PBS, the tissues were fixed
for 20 min in PBS containing 4% paraformaldehyde. Then,
fixation was quenched with 100 mM glycine (pH 7.4) and samples
were permeabilized for 10 min in Triton X-100 and washed in
PBS. Fixed tissues were blocked with solution 1 (75 mM NaCl,
18 mM Na3 citrate, 2% goat serum, 1% BSA, 0.05% Triton X-
100, and 0.02% NaN3) for 2 h at room temperature. The tissues
were stained with F4/80, MR and Dectin-1 primary Antibodies
(goat anti-mouse, Santa-cruz for F4/80; goat anti-rabbit, Santa-
cruz for MR; goat anti-rat, Acris antibodies for Dectin-1) diluted
(1/500) in solution 1 for 48 h at 4uC. Then, tissues were washed in
solution 2 (75 mM NaCl, 18 mM sodium citrate, and 0.05%
Triton X-100) for 1 h30 and rinsed in PBS. The tissues were then
incubated for 1 h at room temperature with Alexa conjugated
secondary antibodies (Alexa 647, 488, 546 for F4/80, MR and
Dectin-1 respectively, Molecular Probes) diluted in solution 1.
Finally, they were washed in solution 1 for 30 min at room
Table 1. Primers sequences used in quantitative PCR
experiments.
Gene sequence
b-actin sense 59AGC CAT GTA CGT AGC CAT CC39
antisense 59CTC TCA GCT GTG GTG GTG AA39
YM-1 sense 59AAT GAT TCC TGC TCC TGT GG39
antisense 59ACT TTG ATG GCC TCA ACC TG39
YM-2 sense 59CAC GGC ACC TCC TAA ATT GT39
antisense 59GCT GGA CCA CCA GGA AAG TA39
TNF-a sense 59AGG CTG TGC ATT GCA CCT CA39
antisense 59GGG ACA GTG ACC TGC ACT GT39
IL-10 sense 59TTT TCA CAG GGG AGA AAT CG39
antisense 59CCA AGC CTT ATC GGA AAT GA39
IL-1b sense 59GAT CCA CAC TCT CCA GCT GCA39
antisense 59CAA CCA ACA AGT GAT ATT CTC CAT G39
IL-6 sense 59AAG TGC ATC ATC GTT GTT CAT ACA39
antisense 59GAG GAT ACC ACT CCC AAC AGA CC39
Arginase1 sense 59AGA GCT GAC AGC AAC CCT GT39
antisense 59GGA TCC AGA AGG TGA TGG AA39
PPARc sense 59AAT CCT TGG CCC TCT GAG AT39
antisense 59TTT TCA AGG GTG CCA GTT TC39
PPARa sense 59GGT CAC CTA CGA GTG GCA TT39
antisense 59GAG GGT TGA GCT CAG TCA GG39
PPARb/d sense 59GTA CTG GCT GTC AGG GTG GT39
antisense 59TGG AGC TCG ATG ACA GTG AC39
CD36 sense 59GCA GAA TCA AGG GAG AGC AC39
antisense 59GAG CAA CTG GTG GAT GGT TT39
Mannose Receptor sense 59ATG CCA AGT GGG AAA ATC TG39
antisense 59TGT AGC AGT GGC CTG CAT AG39
CD11b sense 59AGA TCG TCT TGG CAG ATG CT39
antisense 59GAC TCA GTG AGC CCC ATC AT39
Dectin-1 sense 5959CAT CGT CTC ACC GTA TTA ATG CAT39,
antisense 59CCC AGA ACC ATG GCC CTT39
doi:10.1371/journal.pone.0012828.t001
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temperature. All preparations were mounted with Kaiser’s glycerol
gelatin (Mercks). All microscopy imagery was performed with a
Zeiss LSM 510 (ConfoCor, Zeiss).
Statistical analysis
For each experiment, the data were subjected to one-way
analysis of variance followed by the means multiple comparison
method of Bonferroni-Dunnett. p,0.05 was considered as the
level of statistical significance.
Acknowledgments
We thank Vale´rie Bans, Philippe Batigne from Universite´ Paul Sabatier
Toulouse 3 and Ambiotis and Physiogenex societies for technical
assistance.
Author Contributions
Conceived and designed the experiments: AG RB BP AC. Performed the
experiments: LL AG DO JB AC. Analyzed the data: LL AG BP AC.
Contributed reagents/materials/analysis tools: LP JA. Wrote the paper: LL
JA BP AC. Helpful discussions: AV.
References
1. Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch
in adipose tissue macrophage polarization. J Clin Invest 117(1): 175–184.
2. Tontonoz P, Spiegelman BM (2008) Fat and beyond: the diverse biology of
PPARgamma. Annu Rev Biochem 77: 289–312.
3. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V,
et al. (2007) Macrophage-specific PPARgamma controls alternative activation
and improves insulin resistance. Nature 447(7148): 1116–1120.
4. Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S, Maumus M, et al.
(2008) Remodeling phenotype of human subcutaneous adipose tissue macro-
phages. Circulation 117(6): 806–815.
5. Mantovani A, Allavena P, Sozzani S, Vecchi A, Locati M, et al. (2004)
Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors.
Semin Cancer Biol 14(3): 155–160.
6. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage
activation. Nat Rev Immunol 8(12): 958–969.
7. Khovidhunkit SO, Suwantuntula T, Thaweboon S, Mitrirattanakul S,
Chomkhakhai U, et al. (2009) Xerostomia, hyposalivation, and oral microbiota
in type 2 diabetic patients: a preliminary study. J Med Assoc Thai 92(9):
1220–1228.
8. Lutsey PL, Pankow JS, Bertoni AG, Szklo M, Folsom AR (2009) Serological
evidence of infections and Type 2 diabetes: the MultiEthnic Study of
Atherosclerosis. Diabet Med 26(2): 149–152.
9. Macedo DP, Oliveira NT, Farias AM, Silva VK, Wilheim AB, et al. (2010)
Esophagitis caused by Candida guilliermondii in diabetes mellitus: first reported
case. Med Mycol. pp 1–4.
10. Viswanathan V, Jasmine JJ, Snehalatha C, Ramachandran A (2002) Prevalence
of pathogens in diabetic foot infection in South Indian type 2 diabetic patients.
J Assoc Physicians India 50: 1013–1016.
11. Belazi M, Velegraki A, Fleva A, Gidarakou I, Papanaum L, et al. (2005)
Candidal overgrowth in diabetic patients: potential predisposing factors.
Mycoses 48(3): 192–196.
12. Soysa NS, Samaranayake LP, Ellepola AN (2006) Diabetes mellitus as a
contributory factor in oral candidosis. Diabet Med 23(5): 455–459.
13. Coste A, Dubourdeau M, Linas MD, Cassaing S, Lepert JC, et al. (2003)
PPARgamma promotes mannose receptor gene expression in murine macro-
phages and contributes to the induction of this receptor by IL-13. Immunity
19(3): 329–339.
14. Coste A, Lagane C, Filipe C, Authier H, Gales A, et al. (2008) IL-13 attenuates
gastrointestinal candidiasis in normal and immunodeficient RAG-2(-/-) mice via
peroxisome proliferator-activated receptor-gamma activation. J Immunol 180(7):
4939–4947.
15. Gales A, Conduche A, Bernad J, Lefevre L, Olagnier D, et al. PPARgamma
controls dectin-1 expression required for host antifungal defense against Candida
albicans. PLoS Pathog 6(1): e1000714.
16. Coste A, Linas MD, Cassaing S, Bernad J, Chalmeton S, et al. (2002) A sub-
inhibitory concentration of amphotericin B enhances candidastatic activity of
interferon-gamma- and interleukin-13-treated murine peritoneal macrophages.
J Antimicrob Chemother 49(5): 731–740.
17. Berry A, Balard P, Coste A, Olagnier D, Lagane C, et al. (2007) IL-13 induces
expression of CD36 in human monocytes through PPARgamma activation.
Eur J Immunol 37(6): 1642–52.
18. Aleshin S, Grabeklis S, Hanck T, Sergeeva M, Reiser G (2009) Peroxisome
proliferator-activated receptor (PPAR)-gamma positively controls and PPAR-
alpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes
through a convergence on PPARbeta/delta via mutual control of PPAR
expression levels. Mol Pharmacol 76(2): 414–424.
19. Fernandez-Real JM, Pickup JC (2008) Innate immunity, insulin resistance and
type 2 diabetes. Trends Endocrinol Metab 19(1): 10–16.
20. Shaul ME, Bennett G, Strissel KJ, Greenberg AS, Obin MS (2010) Dynamic,
M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during
high-fat diet—induced obesity in mice. Diabetes 59(5): 1171–81.
21. Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, et al. (2007) Human
adipose tissue macrophages are of an anti-inflammatory phenotype but capable
of excessive pro-inflammatory mediator production. Int J Obes (Lond) 31(9):
1420–1428.
22. Nguyen MT, Favelyukis S, Nguyen AK, Reichart D, Scott PA, et al. (2007) A
subpopulation of macrophages infiltrates hypertrophic adipose tissue and is
activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent
pathways. J Biol Chem 282(48): 35279–92.
23. Martinez FO, Sica A, Mantovani A, Locati M (2008) Macrophage activation
and polarization. Front Biosci 13: 453–461.
24. Vidal-Puig A, Jimenez-Linan M, Lowell BB, Hamann A, Hu E, et al. (1996)
Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
J Clin Invest 97(11): 2553–2561.
25. Zhou J, Wilson KM, Medh JD (2002) Genetic analysis of four novel peroxisome
proliferator activated receptor-gamma splice variants in monkey macrophages.
Biochem Biophys Res Commun 293(1): 274–283.
26. Necela BM, Su W, Thompson EA (2008) Toll-like receptor 4 mediates cross-talk
between peroxisome proliferator-activated receptor gamma and nuclear factor-
kappaB in macrophages. Immunology 125(3): 344–58.
27. Zhou M, Wu R, Dong W, Jacob A, Wang P (2008) Endotoxin downregulates
peroxisome proliferator-activated receptor-gamma via the increase in TNF-
alpha release. Am J Physiol Regul Integr Comp Physiol 294(1): R84–92.
28. Cho HY, Gladwell W, Wang X, Chorley B, Bell D, et al. (2010) Nrf2-Regulated
PPAR{gamma} Expression is Critical to Protection Against Acute Lung Injury
in Mice. Am J Respir Crit Care Med.
29. Jiang T, Huang Z, Lin Y, Zhang Z, Fang D, et al. (2010) The protective role of
Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes 59(4): 850–60.
30. Szanto A, Nagy L (2008) The many faces of PPARgamma: anti-inflammatory by
any means? Immunobiology 213(9-10): 789–803.
31. Fruchart JC (2009) Peroxisome proliferator-activated receptor-alpha (PPAR-
alpha): at the crossroads of obesity, diabetes and cardiovascular disease.
Atherosclerosis 205(1): 1–8.
32. Forsyth CB, Plow EF, Zhang L (1998) Interaction of the fungal pathogen
Candida albicans with integrin CD11b/CD18: recognition by the I domain is
modulated by the lectin-like domain and the CD18 subunit. J Immunol 161(11):
6198–6205.
33. Caimi G, Montana M, Ferrara F, Porretto F, Musso M, et al. (2003)
Polymorphonuclear leukocyte integrin pattern, at baseline and after activation,
in type 2 diabetic subjects with macrovascular complications. Acta Diabetol
40(1): 14–19.
34. Chang FY, Shaio MF (1995) Decreased cell-mediated immunity in patients with
non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 28(2):
137–146.
35. Greenfield JR, Campbell LV (2006) Relationship between inflammation, insulin
resistance and type 2 diabetes: ‘cause or effect’? Curr Diabetes Rev 2(2):
195–211.
36. Ma XW, Chang ZW, Qin MZ, Sun Y, Huang HL, et al. (2009) Decreased
expression of complement regulatory proteins, CD55 and CD59, on peripheral
blood leucocytes in patients with type 2 diabetes and macrovascular diseases.
Chin Med J (Engl) 122(18): 2123–2128.
37. Fernandes-Santos C, Carneiro RE, de Souza Mendonca L, Aguila MB,
Mandarim-de-Lacerda CA (2009) Pan-PPAR agonist beneficial effects in
overweight mice fed a high-fat high-sucrose diet. Nutrition 25(7-8): 818–827.
38. Kim H, Haluzik M, Gavrilova O, Yakar S, Portas J, et al. (2004)
Thiazolidinediones improve insulin sensitivity in adipose tissue and reduce the
hyperlipidaemia without affecting the hyperglycaemia in a transgenic model of
type 2 diabetes. Diabetologia 47(12): 2215–2225.
39. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM (2003)
Collaborative induction of inflammatory responses by dectin-1 and Toll-like
receptor 2. J Exp Med 197(9): 1107–1117.
M2 Macrophage, Candida Diabetes
PLoS ONE | www.plosone.org 12 September 2010 | Volume 5 | Issue 9 | e12828
